Above proteins are upregulated in glioblastoma, involved in cyclin-dependent kinase regulatory activity, prooncogenic pathways (PI3K/Akt, WNT/β-catenin, TGFβ), migration, invasion, cell cycle progression, and therapy resistance; thus, they are widely explored therapeutic targets.106–110. Here, TGFB1 is linked to glioblastoma.